Ambien vs. Dayvigo

See how Ambien and Dayvigo compare on approved uses, dosing, side effects, and cost.

Andre Stone | MD

Medically reviewed by Andre Stone | MD, University of Pittsburgh School of Medicine on August 25th, 2026.

Key Takeaways

  • Ambien is FDA-approved only for short-term insomnia, while Dayvigo has 12-month trial data supporting sustained use without rebound insomnia after stopping.

  • Both drugs are Schedule IV controlled substances and carry an FDA boxed warning about dangerous complex sleep behaviors. Both can also impair alertness the next day, but their complete warnings and precautions are not identical.

  • Ambien enhances GABA activity, while Dayvigo blocks orexin receptors. Dizziness can occur with either drug, and results from separate trials cannot reliably show that one causes less dizziness than the other.

Ambien vs. Dayvigo Drug Summary

Ambien

Ambien (zolpidem) is a non-benzodiazepine sedative-hypnotic that binds GABA-A receptors to help people fall asleep faster. It is FDA-approved for short-term insomnia and is taken as a single tablet once nightly on an empty stomach.

Dayvigo

Dayvigo (lemborexant) is a dual orexin receptor antagonist that blocks wake-promoting brain signals instead of boosting GABA activity. It is FDA-approved for insomnia involving trouble falling asleep, staying asleep, or both, and is taken as one tablet nightly.

Ambien vs. Dayvigo Side Effects

Ambien

Most common
headache (up to 19%)
diarrhea (up to 3%)
dizziness (up to 23.5%)
somnolence/drowsiness (up to 15%)

Dayvigo

Most common
headache (up to 6%)
diarrhea (up to 3%)
somnolence (up to 10%)
nasopharyngitis (up to 3%)

Ambien vs. Dayvigo Dosage

Ambien

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once nightly At the start
Maximum dose 10 mg once nightly If needed
Dose changes 1 increase As tolerated

Dayvigo

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once nightly At the start
Maximum dose 10 mg once nightly If needed
Dose changes 1 increase As tolerated

Ambien vs. Dayvigo Indications

Ambien

Ambien is FDA-approved for short-term treatment of insomnia in people who have trouble falling asleep. It is not approved for long-term nightly use or for use in children.

  • Difficulty falling asleep (sleep-onset insomnia)

  • Short-term use only, typically a few weeks

  • Not approved for children

  • Not approved for chronic nightly use

Dayvigo

Dayvigo is FDA-approved for insomnia in adults who have trouble falling asleep, staying asleep, or both. It is not approved for use in children or for narcolepsy.

  • Difficulty falling asleep or staying asleep

  • Supported by 12-month trial data

  • Not approved for children

  • Not approved for narcolepsy

Ambien vs. Dayvigo Pros and Cons

Ambien

Ambien has decades of clinical use, a low-cost generic option, and dosing that most prescribers know well. It is only approved for short-term use, and its GABA-based mechanism carries a well-documented next-day impairment risk, especially at the 10 mg dose.

Pros

  • Inexpensive generic, roughly $15-$90/month without insurance

  • Long track record since 1992 FDA approval

  • Faster onset when taken on an empty stomach

  • Lower starting dose specifically defined for women

Cons

  • Only approved for short-term insomnia treatment

  • Higher next-day impairment risk at the 10 mg dose

  • More reports of dizziness than newer options

  • No long-term trial data supporting nightly use

Dayvigo

Dayvigo works through a newer orexin-blocking mechanism and has 12-month trial data showing sustained effect without rebound insomnia after stopping. It has no generic version yet, so it costs significantly more out of pocket than Ambien.

Pros

  • Approved for both falling asleep and staying asleep

  • 12-month data shows no rebound insomnia on stopping

  • Lower rates of dizziness and next-day drowsiness overall

  • Different mechanism may help those who don't respond to GABA drugs

Cons

  • No generic yet, roughly $135-$400/month without insurance

  • Newer drug with less long-term real-world use

  • Interacts with CYP3A inhibitors/inducers, limiting drug combinations

  • Carries a warning for worsening depression or suicidal thoughts

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.

Compare Ambien and Dayvigo

Chat Now